These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16644741)

  • 1. Nuclear localizing sequences: an innovative way to improve targeted radiotherapy.
    O'Donnell RT
    J Nucl Med; 2006 May; 47(5):738-9. PubMed ID: 16644741
    [No Abstract]   [Full Text] [Related]  

  • 2. Radionuclide therapy in oncology: repeated administrations of high dose rate radiopharmaceuticals.
    Palmedo H; Bucerius J
    Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1556. PubMed ID: 15372210
    [No Abstract]   [Full Text] [Related]  

  • 3. Radionuclide therapy in oncology: the dawning of its concomitant use with other modalities?
    Valdés Olmos RA; Hoefnagel CA
    Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):929-31. PubMed ID: 15042326
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiobiologic principles in radionuclide therapy.
    Kassis AI; Adelstein SJ
    J Nucl Med; 2005 Jan; 46 Suppl 1():4S-12S. PubMed ID: 15653646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic targeted radionuclide therapy: potential new areas.
    Wong JY
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S74-82. PubMed ID: 16979445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovative techniques in radiation therapy: editorial, overview, and crystal ball gaze to the future.
    Webb S; Evans PM
    Semin Radiat Oncol; 2006 Oct; 16(4):193-8. PubMed ID: 17010901
    [No Abstract]   [Full Text] [Related]  

  • 7. Receptor radionuclide therapy of tumors: a road from basic research to clinical applications.
    Bodei L; Paganelli G; Mariani G
    J Nucl Med; 2006 Mar; 47(3):375-7. PubMed ID: 16513604
    [No Abstract]   [Full Text] [Related]  

  • 8. Progress in systemic radiotherapy.
    Order SE
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):631; author reply 631. PubMed ID: 15667991
    [No Abstract]   [Full Text] [Related]  

  • 9. Dose painting and theragnostic imaging: towards the prescription, planning and delivery of biologically targeted dose distributions in external beam radiation oncology.
    Bentzen SM
    Cancer Treat Res; 2008; 139():41-62. PubMed ID: 18236711
    [No Abstract]   [Full Text] [Related]  

  • 10. Delivery systems for the targeted radiotherapy of cancer. Preface.
    Sofou S; Yu YB
    Adv Drug Deliv Rev; 2008 Sep; 60(12):1317-8. PubMed ID: 18538443
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeted α-Therapy.
    Brechbiel MW
    Cancer Biother Radiopharm; 2020 Aug; 35(6):397. PubMed ID: 32503377
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeted Radiotherapy with Alpha-Particle Emitting Radionuclides Seminar, November 18, 2004, Cracow, Poland.
    Zalutsky MR; Petelenz B
    Nucl Med Rev Cent East Eur; 2004; 7(2):195. PubMed ID: 15968616
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeted radiotherapy: is the "Holy Grail" in sight?
    Mothersill C; Seymour CB
    J Nucl Med; 2006 Jun; 47(6):899-900. PubMed ID: 16741295
    [No Abstract]   [Full Text] [Related]  

  • 14. [Radiation biology. Knowledge combines nuclear medicine and radiation oncology].
    Kotzerke J; Baumann M
    Nuklearmedizin; 2010; 49 Suppl 1():S1-2. PubMed ID: 21152685
    [No Abstract]   [Full Text] [Related]  

  • 15. Advances in nuclear oncology: microspheres for internal radionuclide therapy of liver tumours.
    Nijsen JF; van het Schip AD; Hennink WE; Rook DW; van Rijk PP; de Klerk JM
    Curr Med Chem; 2002 Jan; 9(1):73-82. PubMed ID: 11860349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic immunology of antibody targeted radiotherapy.
    Wong JY
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S8-14. PubMed ID: 16979446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials in molecular radiotherapy-Tribulations and Triumphs Report of the NCRI CTRad meeting held at the Lift Islington, 8 June 2018.
    Falzone N; Gregory R; Aldridge M; Terry SY; Flux G
    Br J Radiol; 2019 Aug; 92(1100):20190117. PubMed ID: 30982344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiopharmaceuticals for targeted radiotherapy.
    Marques F; Paulo A; Campello MP; Lacerda S; Vitor RF; Gano L; Delgado R; Santos I
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):601-4. PubMed ID: 16604708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are radiation oncologists serious about systemic radiation therapy and if not, should we be?
    Wallner PE; Coleman CN; Brechbiel M; Milenic D; Tripuraneni P
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):1-2. PubMed ID: 15337532
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides.
    Boyd M; Ross SC; Dorrens J; Fullerton NE; Tan KW; Zalutsky MR; Mairs RJ
    J Nucl Med; 2006 Jun; 47(6):1007-15. PubMed ID: 16741311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.